Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Bronchial blocker versus double‑lumen tube for one‑lung ventilation in people with obesity

Official title: One-lung Ventilation With Double-Lumen Tubes and Bronchial Blockers in Obese Patients Undergoing Lung Resection

Run by Hospital Son Espases · NCT07031986 · Data updated 2026-11-12

This study tests whether bronchial blockers or double‑lumen tubes lead to less low oxygen (hypoxia) during one‑lung ventilation for people with obesity having lung resection surgery.

More One-lung Ventilation trials

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment46 (estimated)
SponsorHospital Son Espases
Academic / other
Locations1 site (Palma de Mallorca, Balearic Islands)
StatusRecruiting
StartedAugust 15, 2024
Main results expectedApril 2026
Study endsApril 2026
Registry record updatedJune 22, 2025
Trial IDNCT07031986 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with BMI ≥ 30 kg/m2 who have diagnostic or clinical suspicion of lung cancer and are scheduled for elective lung resection requiring one‑lung ventilation are the intended participants.

Probably not a fit

Patients with airway anatomic alterations that contraindicate double‑lumen tubes, emergency surgery cases, or those not undergoing lung resection would not be eligible and are unlikely to benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial compares two airway devices—bronchial blockers and double‑lumen tubes—in obese adults undergoing planned lung resection (lobectomy, segmentectomy, or wedge) by VATS or thoracotomy that require one‑lung ventilation. Researchers will record intraoperative oxygen levels and other safety and efficacy measures while standard anesthesia care is provided. Patients will be assigned to receive one of the two devices during their surgery and no extra tasks are required. The primary focus is whether the choice of device changes the frequency or severity of intraoperative hypoxia.

Why it matters

Potential benefit: If successful, the results could identify which device reduces intraoperative hypoxia and complications, helping anesthesiologists choose the safer option for obese patients.

How similar studies have gone: Previous comparisons of bronchial blockers and double‑lumen tubes have produced mixed results and obese‑specific data are limited, so this trial addresses a relatively under‑studied subgroup.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* BMI ≥ 30 kg/m2
* Diagnostic or clinical suspicion of lung cancer
* Lung resection surgery (lobectomy, segmentectomy or wedge resection) by VATS or thoracotomy, requiring one-lung ventilation.
* Use of bronchial blocker or double-lumen tube for one-lung ventilation.

Exclusion Criteria:

* Patients with evident anatomic alterations, in which double-lumen tubes may be contraindicated.
* Emergency surgeries.

Where it's running

  • Hospital Son Espases
    Palma de Mallorca, Balearic Islands, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.